RT Journal Article
SR Electronic
T1 Supplementation with Berry Juice and Vitamin E Ameliorates Blood Cholesterol Level and Alters Gut Microbiota Composition
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.05.22.23290321
DO 10.1101/2023.05.22.23290321
A1 Chen, Bangwei
A1 Li, Yaxin
A1 Li, Zhiming
A1 Hu, Xiaojie
A1 Zhen, Hefu
A1 Chen, Hongyun
A1 Nie, Chao
A1 Hou, Yong
A1 Jin, Xin
A1 Xiao, Liang
A1 Li, Tao
YR 2023
UL http://medrxiv.org/content/early/2023/05/28/2023.05.22.23290321.abstract
AB Scope Antioxidants, including vitamin E (VE) and grape seed extract, as anti-aging supplementation have been widely used to improve human health. However, the role of gut microbiota in dietary antioxidant supplementation is debatable. This study aimed to assess the longitudinal impact of dietary supplementation with antioxidant compounds on body health and the gut microbiota.Methods and results One hundred and twenty healthy individuals were randomly divided into a placebo group (amylodextrin) and three experimental groups ingesting different supplement (VE, grape seed extract, or mixed berry juice). Blood and fecal samples were collected during three intervention phases. We found that VE and mixed berry juice ameliorated blood cholesterol levels by reducing the levels of low-density lipoprotein cholesterol (LDL-C) in healthy volunteers. After the intervention, there was an increase in the relative abundance of short-chain fatty acid (SCFA)-producing bacteria and bile acid metabolizers. Specifically, the abundances of Lachnospira sp. and Faecalibacterium spp. increased in the VE and berry juice groups. Interestingly, the gut microbiota of poor responders harbored a greater proportion of disease-associated bacterial species.Conclusion Juice and VE could promote health by lowering LDL-C, partly and indirectly by affecting gut bacteria with the ability to produce SCFAs or metabolize bile acids.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialChiCTR2100050567Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The procedures involving human participants were reviewed and approved by the Institutional Review Board of BGI (No. BGI-IRB 20133). Affiliation: BGI-Shenzhen.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data that support the findings of this study are available from the CNGB Sequence Archive (CNSA) of the China National GeneBank Database (CNGBdb). Restrictions apply to the availability of these data, which were used under license for this study. Data are available from the corresponding authors with the permission of CNGBdb.BWAburrows-wheeler alignerCNSACNGB sequence archiveCNGBdbchina national genebank databaseCEPTcholesteryl ester transfer proteinFDRfalse discovery rateGSEgrape seed extractHMG-CoA3-hydroxy-3-methylglutaryl coenzyme AKEGGkyoto encyclopedia for genes and genomesKOKEGG orthologyLDL-Clow-density lipoprotein cholesterolLDL3-7low-density LDLLDL1, LDL2large LDLNLRneutrophil-to-lymphocyte ratioPERMANOVApermutational multivariate analysis of variancePCoAprincipal coordinates analysisRCTsrandomized controlled trialsSCFAsshort-chain fatty acidsSIIsystemic immune-inflammation indexUHGGunified human gastrointestinal genomeVEvitamin E